Rooming-in for Infants at Risk of Neonatal Abstinence Syndrome

American Journal of Perinatology

Volumn 33, Issue 5, 2016, Pages 495-501

  McKnight, Sarah ^a   Coo, Helen ^a   Davies, Gregory ^a   Holmes, Belinda ^b   Newman, Adam ^a   Newton, Lynn ^b   Dow, Kimberly ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

length of stay; neonatal abstinence syndrome; opioids; rooming in; treatment

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FEMALE; HEALTH CARE UTILIZATION; HIGH RISK INFANT; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RISK REDUCTION; ROOMING IN; WITHDRAWAL SYNDROME; ADULT; BOTTLE FEEDING; BREAST FEEDING; CANADA; NEONATAL ABSTINENCE SYNDROME; NEONATAL INTENSIVE CARE UNIT; NEWBORN CARE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PROCEDURES; RISK; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER; UTILIZATION; YOUNG ADULT;

METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ANALGESICS, OPIOID; BOTTLE FEEDING; BREAST FEEDING; CANADA; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; LENGTH OF STAY; MALE; METHADONE; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK; ROOMING-IN CARE; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84947997321     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1566295     Document Type: Article

References (22)

1. Hayes M. J., Brown M. S. Epidemic of prescription opiate abuse and neonatal abstinence. JAMA: 2012; 307 18 1974 1975
2. Abrahams R., Chase C., Desmoulin J., et al. The opioid dependent mother and newborn- an update. The 6th Annual Ivey Symposium. J Popul Ther Clin Pharmacol: 2012; 19 1 e73 e77
3. Dow K., Ordean A., Murphy-Oikonen J., et al. Neonatal Abstinence Syndrome Work Group. Neonatal abstinence syndrome clinical practice guidelines for Ontario. J Popul Ther Clin Pharmacol: 2012; 19 3 e488 e506
4. Patrick S. W., Schumacher R. E., Benneyworth B. D., Krans E. E., McAllister J. M., Davis M. M. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA: 2012; 307 18 1934 1940
5. Anisfeld E., Lipper E. Early contact, social support, and mother-infant bonding. Pediatrics: 1983; 72 1 79 83
6. Kennell J. H., Klaus M. H. Bonding: recent observations that alter perinatal care. Pediatr Rev: 1998; 19 1 4 12
7. Saiki T., Lee S., Hannam S., Greenough A. Neonatal abstinence syndrome - postnatal ward versus neonatal unit management. Eur J Pediatr: 2010; 169 1 95 98
8. Abrahams R. R., Kelly S. A., Payne S., Thiessen P. N., Mackintosh J., Janssen P. A. Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Can Fam Physician: 2007; 53 10 1722 1730
9. Hünseler C., Brückle M., Roth B., Kribs A. Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience. Klin Padiatr: 2013; 225 5 247 251
10. Newman A., Dow K., Davies G., et al. Introduction and evaluation of rooming-in as standard care for infants of opioid-dependent mothers at a tertiary care hospital. Can Fam Physician. In press
11. Abrahams R. R., MacKay-Dunn M. H., Nevmerjitskaia V., MacRae G. S., Payne S. P., Hodgson Z. G. An evaluation of rooming-in among substance-exposed newborns in British Columbia. J Obstet Gynaecol Can: 2010; 32 9 866 871
12. Bagley S. M., Wachman E. M., Holland E., Brogly S. B. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pract: 2014; 9 1 19
13. Hudak M. L., Tan R. C.; Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics: 2012; 129 2 e540 e560
14. Kaltenbach K., Holbrook A. M., Coyle M. G., et al. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Addiction: 2012; 107 01 45 52
15. Jones H. E., Heil S. H., Tuten M., et al. Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes. Drug Alcohol Depend: 2013; 131 3 271 277
16. Johnson K., Greenough A., Gerada C. Maternal drug use and length of neonatal unit stay. Addiction: 2003; 98 6 785 789
17. Dryden C., Young D., Hepburn M., Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG: 2009; 116 5 665 671
18. Abdel-Latif M. E., Pinner J., Clews S., Cooke F., Lui K., Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics: 2006; 117 6 e1163 e1169
19. Ordean A., Kahan M., Graves L., Abrahams R., Kim T. Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. J Obstet Gynaecol Can: 2015; 37 3 252 257
20. Eccles M., Grimshaw J., Campbell M., Ramsay C. Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care: 2003; 12 1 47 52
21. Fan E., Laupacis A., Pronovost P. J., Guyatt G. H., Needham D. M. How to use an article about quality improvement. JAMA: 2010; 304 20 2279 2287
22. Jones H. E., Heil S. H., Baewert A., et al. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction: 2012; 107 01 5 27